Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Webster

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 27, 2009
Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transportKristina K Wolf, Sapana Vora, Lindsey O Webster, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5W Orr, S H Phan, J Varani, et al.
Toxicologic Pathology|October 31, 2015
Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance ImagingStephen C Lenhard, Mally Lev, Lindsey O Webster, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 5, 2015
Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolamMelinda J Reese, Gary D Bowers, Joan E Humphreys, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Rational use of in vitro P-glycoprotein assays in drug discoveryJ W Polli, S A Wring, J E Humphreys, et al.
The American Journal of Pathology|October 1, 1979
Complement fragments, alveolar macrophages, and alveolitisP M Henson, K McCarthy, G L Larsen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substratesJarkko Rautio, Joan E Humphreys, Lindsey O Webster, et al.
Journal of Biochemical and Molecular Toxicology|April 15, 2006
Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytesRichard A Graham, Lindsey O Tyler, Wojciech L Krol, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugsKelly M Mahar Doan, Joan E Humphreys, Lindsey O Webster, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 8, 2012
In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitorMelinda J Reese, Paul M Savina, Grant T Generaux, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 27, 2009
Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transportKristina K Wolf, Sapana Vora, Lindsey O Webster, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5W Orr, S H Phan, J Varani, et al.
Toxicologic Pathology|October 31, 2015
Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance ImagingStephen C Lenhard, Mally Lev, Lindsey O Webster, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 5, 2015
Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolamMelinda J Reese, Gary D Bowers, Joan E Humphreys, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Rational use of in vitro P-glycoprotein assays in drug discoveryJ W Polli, S A Wring, J E Humphreys, et al.
The American Journal of Pathology|October 1, 1979
Complement fragments, alveolar macrophages, and alveolitisP M Henson, K McCarthy, G L Larsen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substratesJarkko Rautio, Joan E Humphreys, Lindsey O Webster, et al.
Journal of Biochemical and Molecular Toxicology|April 15, 2006
Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytesRichard A Graham, Lindsey O Tyler, Wojciech L Krol, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugsKelly M Mahar Doan, Joan E Humphreys, Lindsey O Webster, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 8, 2012
In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitorMelinda J Reese, Paul M Savina, Grant T Generaux, et al.
Pageof 9